The final AMYPAD General Assembly Meeting will take place on 22 and 23 September 2022 in Amsterdam (Netherlands).
Further details to be confirmed.
This project has received funding from the Innovative Medicines Initiative 2 Joint undertaking under grant agreement No 115952. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.